- Presentations
- 4
- Markets
- 1
Crexont is a brand of Carbidopa and Levodopa marketed by Amneal Pharmaceuticals, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Carbidopa and Levodopa
- Brand owner
- Amneal Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 35 mg/140 mg extended-release capsule, 52.5 mg/210 mg extended-release capsule, 70 mg/280 mg extended-release capsule, 87.5 mg/350 mg extended-release capsule
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Crexont 35 mg/140 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
| Crexont 52.5 mg/210 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
| Crexont 70 mg/280 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
| Crexont 87.5 mg/350 mg extended-release capsuleOral | Amneal Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Carbidopa and Levodopa.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Crexont
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.